Nouveau Life Pharmaceuticals, Inc. (NOUV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 21, 2025, 10:13 AM EDT
Nouveau Life Pharmaceuticals Company Description
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products.
It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012.
Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida.
Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
Nouveau Life Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Brian Shibley |
Contact Details
Address: 401 East Las Olas Boulevard Ft. Lauderdale, Nevada 33301 United States | |
| Phone | 954-903-2993 |
Stock Details
| Ticker Symbol | NOUV |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US66979K1034 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Brian Shibley | Chairman of the Board, Chief Executive Officer and President |
| Douglas Dickie | Chief Financial Officer and Director |
| Darcy Penner | Manager of Investor Relations |
| Rolly Hein | Acting Vice President and Director |
| Warren Wheeler | Treasurer, Secretary and Director |